Claire Aitchison of Independent Investment Research provides comprehensive research coverage and commentary for listed managed investments. Here is the latest update.
29 May 2022
1300 794 893
Claire has over 13 years' experience as an analyst specialising in equities and managed investments. Claire is the Lead analyst with respect to small cap research mandates at Independent Investment Research. Previously, she was employed at Aegis Equities Research and joined IIR when that business was sold to Morningstar. She has a Bachelor of Commerce with Distinction and a Grad Diploma in Accounting from Deakin University.
Claire Aitchison of Independent Investment Research provides comprehensive research coverage and commentary for listed managed investments. Here is the latest update.
Claire Aitchison of Independent Investment Research provides comprehensive research coverage and commentary for listed managed investments. Here is the latest update.
Claire Aitchison of Independent Investment Research provides comprehensive research coverage and commentary for listed managed investments. Here is the latest update.
Claire Aitchison of Independent Investment Research provides comprehensive research coverage and commentary for listed managed investments. Here is the latest update.
Here are the listed investments making news this month, including updates on dividends, capital raisings and more.
These are the major changes and developments within the listed investment space in the past month.
Here is the latest information on new listings, mergers, distributions and dividends for listed investments over the past month.
Here is the latest news on Pengana International Equities (PIA), MCP Master Income Trust (MXT), WAM Strategic Value (WAR) and more.
Here are five pharma & biotech companies that have risen on positive news during the past month.
We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.
Let’s look at CSL, Fisher & Paykel Healthcare, Cochlear, Resmed and Ansell.
